{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:25:43Z","timestamp":1782955543955,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115281","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T19:18:42Z","timestamp":1756235922000},"page":"115281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Therapeutic potential of the novel anthraquinone compound ESE in T2DM mice by inhibiting of TLR4\/MyD88\/NF-\u03baB pathway"],"prefix":"10.1016","volume":"164","author":[{"given":"Dongjie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaorun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2025.115281_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25081987","article-title":"Type 2 diabetes mellitus: a review of multi-target drugs","volume":"25","author":"Artasensi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.115281_bb0040","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.intimp.2025.115281_bb0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/0929866530666230509140515","article-title":"Role of fibrinogen in Type-2 diabetes mellitus with diabetic neuropathy and its preliminary mechanism","volume":"30","author":"Wei","year":"2023","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.intimp.2025.115281_bb0055","article-title":"Effect of GLP-1 receptor agonists on renal functions and diabetic nephropathy in type 2 diabetes mellitus (T2DM) patients: a systematic review and meta-analysis","author":"Mohamed","year":"2024","journal-title":"Cureus"},{"issue":"24","key":"10.1016\/j.intimp.2025.115281_bb0060","article-title":"Drug therapies for diabetes","volume":"24","author":"Sibony","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115281_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080806","article-title":"Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus","volume":"14","author":"Blahova","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.intimp.2025.115281_bb0020","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/pharmaceutics15092321","article-title":"Natural bioactivecompounds from marine invertebrates that modulate key targets implicated in the onsetof type 2 diabetes mellitus (T2DM) and its complications","volume":"15","author":"Casertano","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115281_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.06.006","article-title":"Emodin regulates the autophagy via the miR-371a-5p\/PTEN axis to inhibit hepatic malignancy","volume":"619","author":"Wu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.intimp.2025.115281_bb0025","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.16156","article-title":"Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation of glutaminase 1","volume":"180","author":"Chen","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115281_bb0010","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/j.xphs.2020.09.030","article-title":"Improved solubility and Oral absorption of Emodin-nicotinamide Cocrystal over Emodin with PVP as a solubility enhancer and crystallization inhibitor","volume":"109","author":"Ban","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2025.115281_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115281_bb0035","article-title":"Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors","volume":"27","author":"Gasmi","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115281_bb0105","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2147\/DMSO.S377776","article-title":"Association of lipopolysaccharide-toll-like receptor 4 signaling and microalbuminuria in patients with type 2 diabetes mellitus","volume":"15","author":"Zhang","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"19","key":"10.1016\/j.intimp.2025.115281_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910802","article-title":"Changes in stress-mediated markers in a human cardiomyocyte cell line under hyperglycemia","volume":"22","author":"Thakur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115281_bb0050","article-title":"Hyperglycaemia amplifies TLR-mediated inflammatory response of M(IL4) macrophages to dyslipidemic ligands","author":"Luis Ernesto","year":"2024","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115281_bb0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjophthalmol-2013-303201","article-title":"Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in <>Ins2Akita<\/i> mice","volume":"97","author":"Vagaja","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115281_bb0045","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1039\/D3FO00559C","article-title":"Lycopene ameliorates islet function and down-regulates the TLR4\/MyD88\/NF-\u03baB pathway in diabetic mice and Min6 cells","volume":"14","author":"Liu","year":"2023","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.intimp.2025.115281_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"17","author":"Wang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115281_bb0100","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1002\/ptr.7230","article-title":"Synergistic effect of combined treatment with baicalin and emodin on DSS-induced colitis in mouse","volume":"35","author":"Xu","year":"2021","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115281_bb0095","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/nau.25540","article-title":"Emodin suppresses mast cell migration via modulating the JAK2\/STAT3\/JMJD3\/CXCR3 signaling to prevent cystitis","volume":"43","author":"Xin","year":"2024","journal-title":"Neurourol.Urodyn."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:53:44Z","timestamp":1758786824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925012718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"alternative-id":["S1567576925012718"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115281","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of the novel anthraquinone compound ESE in T2DM mice by inhibiting of TLR4\/MyD88\/NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115281"}}